Knowledge, awareness, and attitude among pharmacists regarding the risk estimation of cardiovascular disease in Jordan: Immersion of lipid-lowering agents

Knowledge, awareness, and attitude among pharmacists regarding the risk estimation of cardiovascular disease in Jordan: Immersion of lipid-lowering agents

The Risk Estimation of Cardiovascular Disease (CVD) is an important factor for predicting the incidence of cardiovascular events in a given population. This study aimed to assess the knowledge, awareness, and attitude of pharmacists in Jordan regarding the risk estimation of CVD and the use of lipid...

Full description

Bibliographic Details
Main Authors:	Abeer M. Rababa'h, Mera Ababneh, Nour N. Abedalqader, Salah Eldien Altarabsheh
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Series:	Heliyon
Subjects:	Attitude Risk Estimation Pharmacy Atherosclerosis ASCVD assessment
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023064964

Similar Items

Seasonal influenza vaccination among older adults in Jordan: prevalence, knowledge, and attitudes
by: Mera Ababneh, et al.
Published: (2020-09-01)

Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease
by: Xiao-Lan Zhao, et al.
Published: (2025-01-01)

HDL-Based Therapy: Vascular Protection at All Stages
by: Anastasia V. Poznyak, et al.
Published: (2023-02-01)

Lipoprotein(a) Modulates Carotid Atherosclerosis in Metabolic Syndrome
by: Anna Laura Cremonini, et al.
Published: (2022-06-01)

Increasing provider awareness of Lp(a) testing for patients at risk for cardiovascular disease: A comparative study
by: Wael E. Eid, et al.
Published: (2025-03-01)

Incidence and risk factors regarding atherosclerotic cardiovascular disease in middle-aged and elderly people with HIV treated in Chongqing, China
by: Min Liu, et al.
Published: (2024-12-01)

A tool to help patients visualize ASCVD risk and the potential impact of risk-lowering interventions
by: Keegan Mendez, et al.
Published: (2022-12-01)

Dyslipidemia in youth: Epidemiology, pathophysiology, screening, management, and treatment: A review of the literature
by: Shahla V Esfarjani, et al.
Published: (2022-01-01)

The Impact of an Educational Intervention on Enhancing Clinical Knowledge of Physicians and Pharmacists Regarding Statins and Monitoring Parameters: The Experience of a Tertiary Teaching Hospital
by: Al-Ashwal FY, et al.
Published: (2024-04-01)

Lipoprotein(a) and its impact on cardiovascular disease – the Polish perspective: design and first results of the Zabrze-Lipoprotein(a) Registry
by: Krzysztof Dyrbuś, et al.
Published: (2024-08-01)

Lipoprotein (a) Testing in Patients With Atherosclerotic Cardiovascular Disease in 5 Large US Health Systems
by: Nishant P. Shah, et al.
Published: (2024-11-01)

Managing dyslipidaemia in young adults
by: Jamshed J. Dalal, et al.
Published: (2024-03-01)

Patient experiences align with the familial hypercholesterolemia global call to action
by: Laney K. Jones, et al.
Published: (2022-06-01)

Sleep duration, baseline cardiovascular risk, inflammation and incident cardiovascular mortality in ambulatory U.S. Adults: National health and nutrition examination survey
by: Kartik Gupta, et al.
Published: (2021-12-01)

Letter to the Editor in response to “Response to Kovanen PT, et al. Letter to the Editor” for original article COVID-19 increases risk of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD
by: Kelly D. Myers, et al.
Published: (2021-09-01)

Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study
by: Xingdi Hu, et al.
Published: (2023-06-01)

The prevalence, risk factors and lifestyle patterns of Jordanian females with premenstrual syndrome: a cross-sectional study
by: Mera A Ababneh, et al.
Published: (2023-10-01)

Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients. Beyond LDL cholesterol and hypolipidemic treatment
by: Dimitrios Delialis, et al.
Published: (2022-07-01)

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
by: Chen CC, et al.
Published: (2018-12-01)

Contraceptives Knowledge and Perception: A Cross-Sectional Study Among Future Pharmacists in Jordan
by: Al-Shami KM, et al.
Published: (2023-10-01)

Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting
by: Arrigo F. G. Cicero, et al.
Published: (2023-12-01)

A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation study
by: Yu-Chung Hsiao, et al.
Published: (2024-06-01)

Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular disease
by: Danh Q. Nguyen, et al.
Published: (2024-06-01)

Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity
by: Ashish Sarraju, et al.
Published: (2024-03-01)

Impact of the COVID-19 pandemic on the management of risk factors in patients with stable atherosclerotic vascular disease
by: Dean G. Karalis, et al.
Published: (2023-06-01)

Identification of Dysbetalipoproteinemia by an Enhanced Sampson-NIH Equation for Very Low-Density Lipoprotein-Cholesterol
by: Maureen Sampson, et al.
Published: (2022-07-01)

Coronary artery calcium and atherosclerotic cardiovascular disease risk in women with early menopause: The Multi-Ethnic Study of Atherosclerosis (MESA)
by: Jian H. Chu, et al.
Published: (2022-09-01)

Association of cardiovascular risk profile with healthcare expenditure and resource utilization in chronic obstructive pulmonary disease, with and without atherosclerotic cardiovascular disease
by: Zain Jafar, et al.
Published: (2020-09-01)

A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease
by: Aparna Sajja, MD, et al.
Published: (2021-09-01)

The impact of pharmacist-led educational intervention on pneumococcal vaccine awareness and acceptance among elderly in Jordan
by: Eman Y. Abu-rish, et al.
Published: (2021-04-01)

Community-dwelling older adults’ awareness of the inappropriate use of proton pump inhibitors
by: Mohammad Rababa, et al.
Published: (2020-10-01)

Pharmacists’ Knowledge, Perceptions, and Practices Regarding Herbal Medicine
by: Catherine Santanello, et al.
Published: (2019-09-01)

Pharmacists’ attitudes and awareness towards the use and safety of herbs in Kuwait.
by: Abahussain NA, et al.
Published: (2007-09-01)

The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience
by: Chad Gier, et al.
Published: (2024-01-01)

Antimicrobial use and mortality among intensive care unit patients with bloodstream infections: implications for stewardship programs
by: Mera A. Ababneh, et al.
Published: (2022-08-01)

A systematic review of Antimicrobial Stewardship Program implementation in Middle Eastern countries
by: Mera A. Ababneh, et al.
Published: (2021-04-01)

Association between the aromatase (CYP19A1) gene variant rs10046 and cardiovascular risk in postmenopausal women
by: Betânia Rodrigues dos Santos, et al.
Published: (2025-01-01)

A LASSO-derived model for the prediction of nonattainment of target LDL-C reduction with PCSK9 inhibitors in patients with atherosclerotic cardiovascular disease
by: Xiaochun Duan, et al.
Published: (2025-02-01)

The Acute Coronary Syndrome Risk in Medically Managed Subjects with Type 2 Diabetes Mellitus
by: Ameya Joshi, et al.
Published: (2024-02-01)

Gender disparities in utilization of statins for low density lipoprotein management across the spectrum of atherosclerotic cardiovascular disease: Insights from the houston methodist cardiovascular disease learning health system registry
by: Izza Shahid, et al.
Published: (2024-09-01)